Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakkum

Showing results (231-240 of 347) with videos related to

Pageof 35
Sort By:
Gynecologic Oncology|November 26, 2018
Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancerBeth E Wagner, Carrie L Langstraat, Michaela E McGree, et al.
Diagnostic Pathology|April 28, 2019
Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal womanAlessandra J Ainsworth, Nooshin K Dashti, Taofic Mounajjed, et al.
Gynecologic Oncology|October 2, 2017
Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancerDiogo Torres, Amanika Kumar, Sumer K Wallace, et al.
Gynecologic Oncology|October 15, 2013
Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancerSanjeev Kumar, Karl C Podratz, Jamie N Bakkum-Gamez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 25, 2026
Patterns of excess and cause-specific mortality in vulvar squamous cell carcinoma: a Surveillance, Epidemiology, and End Results program population-based studyHue T T Tran, Nhi H Doan, Duc V Le, et al.
Gynecologic Oncology|April 8, 2025
ECPPF stratification identifies occult high-risk subgroups in stage I, grade 1 or 2, ≤50 % invasive endometrial cancer: Candidates for adjuvant therapyJesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Gynecologic Oncology|January 8, 2019
Cancer susceptibility gene mutations in type I and II endometrial cancerBeverly Long, Jenna Lilyquist, Amy Weaver, et al.
Chembiochem : a European Journal of Chemical Biology|June 6, 2018
Ultrastructural Imaging of Salmonella-Host Interactions Using Super-resolution Correlative Light-Electron Microscopy of Bioorthogonal PathogensDaphne M van Elsland, Sílvia Pujals, Thomas Bakkum, et al.
Gynecologic Oncology|January 18, 2014
Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomyJamie N Bakkum-Gamez, Andrea Mariani, Sean C Dowdy, et al.
Gynecologic Oncology|October 23, 2012
Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancerMariam M AlHilli, Karl C Podratz, Sean C Dowdy, et al.
Pageof 35

Showing results (231-240 of 347) with videos related to

Sort By:
Pageof 35
Gynecologic Oncology|November 26, 2018
Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancerBeth E Wagner, Carrie L Langstraat, Michaela E McGree, et al.
Diagnostic Pathology|April 28, 2019
Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal womanAlessandra J Ainsworth, Nooshin K Dashti, Taofic Mounajjed, et al.
Gynecologic Oncology|October 2, 2017
Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancerDiogo Torres, Amanika Kumar, Sumer K Wallace, et al.
Gynecologic Oncology|October 15, 2013
Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancerSanjeev Kumar, Karl C Podratz, Jamie N Bakkum-Gamez, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 25, 2026
Patterns of excess and cause-specific mortality in vulvar squamous cell carcinoma: a Surveillance, Epidemiology, and End Results program population-based studyHue T T Tran, Nhi H Doan, Duc V Le, et al.
Gynecologic Oncology|April 8, 2025
ECPPF stratification identifies occult high-risk subgroups in stage I, grade 1 or 2, ≤50 % invasive endometrial cancer: Candidates for adjuvant therapyJesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Gynecologic Oncology|January 8, 2019
Cancer susceptibility gene mutations in type I and II endometrial cancerBeverly Long, Jenna Lilyquist, Amy Weaver, et al.
Chembiochem : a European Journal of Chemical Biology|June 6, 2018
Ultrastructural Imaging of Salmonella-Host Interactions Using Super-resolution Correlative Light-Electron Microscopy of Bioorthogonal PathogensDaphne M van Elsland, Sílvia Pujals, Thomas Bakkum, et al.
Gynecologic Oncology|January 18, 2014
Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomyJamie N Bakkum-Gamez, Andrea Mariani, Sean C Dowdy, et al.
Gynecologic Oncology|October 23, 2012
Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancerMariam M AlHilli, Karl C Podratz, Sean C Dowdy, et al.
Pageof 35